This study focuses on the relationship between SARS-CoV-2-specific CD4+ T cells and antibody responses that persist following COVID-19, which were assessed during the first wave of infections in Boston, Massachusetts, United States, in individuals prior to vaccination. The gene discussed is CD4; the disease is COVID-19.